Total neoadjuvant therapy for locally advanced rectal cancer in developing countries : about an observation in a private congolese clinic.
Mots-clés :
locally advanced rectal cancer, otal neoadjuvant therapyt, OPRARésumé
Locally advanced rectal cancer has benefited and continues to benefit from considerable advances in terms of therapeutic management. Total neoadjuvant therapy has shown benefit over radiotherapy alone or with concomitant chemotherapy in many respects. The case presented and discussed here is that of a Congolese patient diagnosed with locally advanced rectal adenocarcinoma managed by the OPRA regimen with induction chemotherapy who completed his neoadjuvant therapy alternately in his country of origin and abroad despite some toxic effects noted. The management of this case illustrates the possibility of allowing patients from developing countries to benefit from therapeutic advances in the management of cancer disease despite the significant challenges.
Téléchargements
Références
Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. juill 2017;28:iv22‑40.
Liu Z, Meng X, Zhang H, Li Z, Liu J, Sun K, et al. Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer. Nat Commun. déc 2020;11(1):4308.
De Felice F, Crocetti D, Petrucciani N, Belgioia L, Sapienza P, Bulzonetti N, et al. Treatment in locally advanced rectal cancer: a machine learning bibliometric analysis. Ther Adv Gastroenterol. janv 2021;14:175628482110421.
Garcia-Aguilar J, Patil S, Gollub MJ, Kim JK, Yuval JB, Thompson HM, et al. Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy. J Clin Oncol. 10 août 2022;40(23):2546‑56.
Verheij FS, Omer DMR, Williams H, Buckley JT, Lin ST, Qin LX, et al. Sustained organ preservation in patients with rectal cancer treated with total neoadjuvant therapy: Long-term results of the OPRA trial. J Clin Oncol. 1 juin 2023;41(16_suppl):3520‑3520.
Fokas E, Allgäuer M, Polat B, Klautke G, Grabenbauer GG, Fietkau R, et al. Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12. J Clin Oncol. 1 déc 2019;37(34):3212‑22.
